Brief: Jaguar Health - Napo Pharmaceuticals Initiated Commercial Launch Of FDA-Approved Oral Mucositis Prescription Product Gelclair In U.S.
16/10/2024 14:05
Oct 16 (Reuters) - Jaguar Health Inc JAGX.O :
* JAGUAR HEALTH: NAPO PHARMACEUTICALS INITIATED COMMERCIAL
LAUNCH
OF FDA-APPROVED ORAL MUCOSITIS PRESCRIPTION PRODUCT GELCLAIR IN
U.S.
Further company coverage: JAGX.O
((Reuters.Briefs@thomsonreuters.com;))